ArticleDiagnostics (Basel, Switzerland)2022
Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor Treatment.
Paul Gougis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.